Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000930413-09-001260
Filing Date
2009-03-09
Accepted
2009-03-06 19:58:51
Documents
20
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 c56802_10k.htm 10-K 1422099
2 GRAPHIC c56802enzonlogok.jpg GRAPHIC 4525
3 GRAPHIC c56802graph.jpg GRAPHIC 20050
4 c56802_ex10-31.htm EX-10.31 360816
5 GRAPHIC c54382_ex10-3x54x1.jpg GRAPHIC 34079
6 GRAPHIC c54382_ex10-3x56x1.jpg GRAPHIC 35242
7 c56802_ex10-32.htm EX-10.32 20289
8 c56802_ex10-33.htm EX-10.33 11485
9 c56802_ex10-34.htm EX-10.34 24324
10 c56802_ex10-35.htm EX-10.35 3499
11 c56802_ex10-36.htm EX-10.36 31666
12 c56802_ex10-37.htm EX-10.37 27808
13 c56802_ex10-38.htm EX-10.38 27473
14 c56802_ex12-1.htm EX-12.1 35782
15 c56802_ex21-1.htm EX-21.1 2406
16 c56802_ex23.htm EX-23 1956
17 c56802_ex31-1.htm EX-31.1 11606
18 c56802_ex31-2.htm EX-31.2 11607
19 c56802_ex32-1.htm EX-32.1 4187
20 c56802_ex32-2.htm EX-32.2 4203
  Complete submission text file 0000930413-09-001260.txt   2132934
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-12957 | Film No.: 09664625
SIC: 2836 Biological Products, (No Diagnostic Substances)